Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage regimen for a PI-3 kinase inhibitor

Dosage regimen for a PI-3 kinase inhibitor

US Patent 10213432 · Granted Feb 26, 2019

Estimated economic value: $44,498,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2022
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppr2020
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2020
Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhi2019
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2019
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supre2019
Pharmaceutical combinations2018
Pharmaceutical combinations2018
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease2018
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or2018
Combination of a PI3 kinase inhibitor with pacitaxel for use in the treatment or2018
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppr2018